What is he best known for?
The fields of study he is best known for:
- Immune system
- Virus
- Antibody
The scientist’s investigation covers issues in Virology, Immunology, Virus, Simian immunodeficiency virus and Immune system.
His Virology research integrates issues from Smallpox vaccine, Variola virus, Vaccinia, Dryvax and ACAM2000.
His Virus study combines topics from a wide range of disciplines, such as Cytotoxic T cell and CD8.
While the research belongs to areas of Simian immunodeficiency virus, he spends his time largely on the problem of Simian, intersecting his research to questions surrounding Virulence.
His research investigates the connection between Immune system and topics such as Viremia that intersect with problems in Viral replication.
As a part of the same scientific family, Keith A. Reimann mostly works in the field of Cellular immunity, focusing on Immunity and, on occasion, Lentivirus.
His most cited work include:
- Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes (2069 citations)
- Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. (806 citations)
- CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection (710 citations)
What are the main themes of his work throughout his whole career to date?
Keith A. Reimann mainly focuses on Immunology, Virology, Antibody, Simian immunodeficiency virus and Virus.
All of his Immunology and Immune system, CD8, Lymphocyte, T lymphocyte and T cell investigations are sub-components of the entire Immunology study.
He focuses mostly in the field of Virology, narrowing it down to topics relating to Cytotoxic T cell and, in certain cases, Major histocompatibility complex.
His Antibody research is multidisciplinary, incorporating perspectives in Anti cd40, CD40 and Transplant rejection.
His study looks at the relationship between Simian immunodeficiency virus and fields such as Heterologous, as well as how they intersect with chemical problems.
Keith A. Reimann has researched Virus in several fields, including Cellular immunity, Interleukin 21 and Interferon gamma.
He most often published in these fields:
- Immunology (67.50%)
- Virology (57.50%)
- Antibody (43.33%)
What were the highlights of his more recent work (between 2015-2020)?
- Immunology (67.50%)
- Antibody (43.33%)
- Virology (57.50%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Immunology, Antibody, Virology, CD40 and Xenotransplantation.
His Immunology research includes elements of Blockade and Transplantation.
He combines subjects such as Biochemistry, Transplant rejection and Rhesus macaque with his study of Antibody.
His Virology research incorporates elements of Pseudomonas exotoxin and CD3.
His Viral replication study deals with the bigger picture of Virus.
His study of Viremia is a part of Virus.
Between 2015 and 2020, his most popular works were:
- Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft (197 citations)
- Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak (134 citations)
- Biophysical and Functional Characterization of Rhesus Macaque IgG Subclasses. (19 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Antibody
- Virus
Keith A. Reimann spends much of his time researching Antibody, Immunology, Virology, Viral load and Monoclonal antibody.
His research integrates issues of Mucosal immunology, In vitro and Systemic administration in his study of Antibody.
His Immunology research is multidisciplinary, relying on both Function and Transplantation.
Keith A. Reimann studies Virology, namely Bundibugyo virus.
His research in Viral load intersects with topics in Chronic infection, Viral replication and Simian immunodeficiency virus.
To a larger extent, Keith A. Reimann studies Virus with the aim of understanding Viral replication.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
